Cargando…
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
BACKGROUND: Observational studies suggest that immunoglobulin treatment may reduce the frequency of acute exacerbations of COPD (AECOPD). OBJECTIVE: To inform the design of a future randomised control trial (RCT) of intravenous immunoglobulin (IVIG) treatment efficacy for AECOPD prevention. METHODS:...
Autores principales: | Cowan, Juthaporn, Mulpuru, Sunita, Abdallah, Sara J, Chopra, Anchal, Purssell, Andrew, McGuinty, Michaeline, Alvarez, Gonzalo G, Giulivi, Antonio, Corrales-Medina, Vicente, MacFadden, Derek, Boyle, Loree, Hasimja, Delvina, Thavorn, Kednapa, Mallick, Ranjeeta, Aaron, Shawn D, Cameron, D William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650772/ https://www.ncbi.nlm.nih.gov/pubmed/34887657 http://dx.doi.org/10.2147/COPD.S338849 |
Ejemplares similares
-
Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations
por: Cowan, Juthaporn, et al.
Publicado: (2018) -
Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19
por: Abdallah, Sara J., et al.
Publicado: (2021) -
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022) -
Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study
por: Yazji, Bashour, et al.
Publicado: (2022) -
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity
por: McGuinty, Michaeline, et al.
Publicado: (2020)